chr3-78600143-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_002941.4(ROBO1):c.4911A>T(p.Glu1637Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00021 in 1,613,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002941.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ROBO1 | NM_002941.4 | c.4911A>T | p.Glu1637Asp | missense_variant | 30/31 | ENST00000464233.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ROBO1 | ENST00000464233.6 | c.4911A>T | p.Glu1637Asp | missense_variant | 30/31 | 5 | NM_002941.4 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000149 AC: 37AN: 248512Hom.: 0 AF XY: 0.000156 AC XY: 21AN XY: 134818
GnomAD4 exome AF: 0.000224 AC: 327AN: 1460946Hom.: 0 Cov.: 31 AF XY: 0.000211 AC XY: 153AN XY: 726746
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74362
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.4911A>T (p.E1637D) alteration is located in exon 30 (coding exon 29) of the ROBO1 gene. This alteration results from a A to T substitution at nucleotide position 4911, causing the glutamic acid (E) at amino acid position 1637 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 31, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 1637 of the ROBO1 protein (p.Glu1637Asp). This variant is present in population databases (rs201046832, gnomAD 0.03%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ROBO1 protein function. ClinVar contains an entry for this variant (Variation ID: 2373263). This variant has not been reported in the literature in individuals affected with ROBO1-related conditions. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at